As India prepares for one of the world’s biggest vaccination campaigns, the DCGI has authorised the use of two coronavirus vaccines for emergency use- one developed by Oxford University-AstraZeneca ‘Covidshield’ and the other by Bharat Biotech ‘Covaxin’.